Post-Covid-19 Epidemic Era, Antibody Drug Conjugates Industry Development Trend Analysis Report 2023

Report ID: ARS11040 | Category: Healthcare | Pages: 115 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3900.00 Multi User-$6800.00

Report Description
View Table of Contents

Report Summary

The global Antibody Drug Conjugates market size in 2022 is 4564.8 million US dollars, and it is expected to be 11506.8 million US dollars by 2029, with a compound annual growth rate of 14.12% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Antibody Drug Conjugates market include Takeda Pharmaceutical Company Ltd., Hoffmann-La Roche Ltd., Pfizer, Inc., AstraZeneca, and Gilead Sciences, Inc. . The share of the top 3 players in the Antibody Drug Conjugates market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Antibody Drug Conjugates market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Non-cleavable Linker accounted for XX% of Antibody Drug Conjugates market in 2022. Cleavable Linker share of XX%.
Blood Cancer accounted for XX% of the Antibody Drug Conjugates market in 2022. Ovary Cancer accounts for XX%.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Antibody Drug Conjugates Market dynamics, structure by identifying and analyzing the market segments and project the global market size.

In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.

Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapter 2: Analyzes the main companies in the Antibody Drug Conjugates industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 3-5: Segmented the global Antibody Drug Conjugates market by type, application and region. Analyze the revenue and sales of market segments from different perspectives.
Chapters 6-11: Provide North America, EMEA, China, Asia-Pacific and Latin America Antibody Drug Conjugates market type, application, country and player market segmentation revenue data.
Chapter 12: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 13: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Takeda Pharmaceutical Company Ltd.
Hoffmann-La Roche Ltd.
Pfizer, Inc.
AstraZeneca
Gilead Sciences, Inc.
Seagen, Inc.
Astellas Pharma
Seagen, Inc.
Daiichi Sankyo Company Ltd.
GlaxoSmithKline Plc
ADC Therapeutics

Types list
Non-cleavable Linker
Cleavable Linker
Linker less

Application list
Blood Cancer
Ovary Cancer
Breast Cancer
Skin Cancer
Lung Cancer
Brain Tumor
Other Applications

Table of Content

1 Antibody Drug Conjugates Market Introduction and Overview
1.1 Antibody Drug Conjugates Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Players Profiles
2.1  Takeda Pharmaceutical Company Ltd.
2.1.1 Takeda Pharmaceutical Company Ltd. Company Profile
2.1.2 Antibody Drug Conjugates Product Overview
2.1.3 Takeda Pharmaceutical Company Ltd. Antibody Drug Conjugates Market Performance (2018-2023)
2.1.4 Takeda Pharmaceutical Company Ltd. Business Overview
2.2  Hoffmann-La Roche Ltd.
2.2.1 Hoffmann-La Roche Ltd. Company Profile
2.2.2 Antibody Drug Conjugates Product Overview
2.2.3 Hoffmann-La Roche Ltd. Antibody Drug Conjugates Market Performance (2018-2023)
2.2.4 Hoffmann-La Roche Ltd. Business Overview
2.3  Pfizer, Inc.
2.3.1 Pfizer, Inc. Company Profile
2.3.2 Antibody Drug Conjugates Product Overview
2.3.3 Pfizer, Inc. Antibody Drug Conjugates Market Performance (2018-2023)
2.3.4 Pfizer, Inc. Business Overview
2.4  AstraZeneca
2.4.1 AstraZeneca Company Profile
2.4.2 Antibody Drug Conjugates Product Overview
2.4.3 AstraZeneca Antibody Drug Conjugates Market Performance (2018-2023)
2.4.4 AstraZeneca Business Overview
2.5  Gilead Sciences, Inc. 
2.5.1 Gilead Sciences, Inc.  Company Profile
2.5.2 Antibody Drug Conjugates Product Overview
2.5.3 Gilead Sciences, Inc.  Antibody Drug Conjugates Market Performance (2018-2023)
2.5.4 Gilead Sciences, Inc.  Business Overview
2.6  Seagen, Inc.
2.6.1 Seagen, Inc. Company Profile
2.6.2 Antibody Drug Conjugates Product Overview
2.6.3 Seagen, Inc. Antibody Drug Conjugates Market Performance (2018-2023)
2.6.4 Seagen, Inc. Business Overview
2.7  Astellas Pharma
2.7.1 Astellas Pharma Company Profile
2.7.2 Antibody Drug Conjugates Product Overview
2.7.3 Astellas Pharma Antibody Drug Conjugates Market Performance (2018-2023)
2.7.4 Astellas Pharma Business Overview
2.8  Seagen, Inc.
2.8.1 Seagen, Inc. Company Profile
2.8.2 Antibody Drug Conjugates Product Overview
2.8.3 Seagen, Inc. Antibody Drug Conjugates Market Performance (2018-2023)
2.8.4 Seagen, Inc. Business Overview
2.9  Daiichi Sankyo Company Ltd.
2.9.1 Daiichi Sankyo Company Ltd. Company Profile
2.9.2 Antibody Drug Conjugates Product Overview
2.9.3 Daiichi Sankyo Company Ltd. Antibody Drug Conjugates Market Performance (2018-2023)
2.9.4 Daiichi Sankyo Company Ltd. Business Overview
2.10  GlaxoSmithKline Plc
2.10.1 GlaxoSmithKline Plc Company Profile
2.10.2 Antibody Drug Conjugates Product Overview
2.10.3 GlaxoSmithKline Plc Antibody Drug Conjugates Market Performance (2018-2023)
2.10.4 GlaxoSmithKline Plc Business Overview
2.11  ADC Therapeutics
2.11.1 ADC Therapeutics Company Profile
2.11.2 Antibody Drug Conjugates Product Overview
2.11.3 ADC Therapeutics Antibody Drug Conjugates Market Performance (2018-2023)
2.11.4 ADC Therapeutics Business Overview
3 Global Antibody Drug Conjugates Historical and Forecast Market Analysis by Type
3.1 Global Antibody Drug Conjugates Revenue and Market Share by Type
3.2 Global Antibody Drug Conjugates Revenue Market Forecast by Type (2023-2029)
4 Global Antibody Drug Conjugates Historical and Forecast Market Analysis by Application
4.1 Global Antibody Drug Conjugates Revenue Market Share by Application (2018-2023)
4.2 Antibody Drug Conjugates Revenue Market Forecast by Application (2023-2029)
5 Global Market Growth Trends Analysis
5.1 Global Antibody Drug Conjugates Market Size & Forecast (2018-2029)
5.2 Antibody Drug Conjugates Growth Trends Analysis by Regions
5.2.1 Antibody Drug Conjugates Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Antibody Drug Conjugates Historic Market Size by Regions (2018-2023)
5.2.3 Antibody Drug Conjugates Forecasted Market Size by Regions (2023-2029)
5.2.4 North America Antibody Drug Conjugates Market Size & Forecast (2018-2029)
5.2.5 Europe Antibody Drug Conjugates Market Size & Forecast (2018-2029)
5.2.6 China Antibody Drug Conjugates Market Size & Forecast (2018-2029)
5.2.7 Asia-Pacific (Excluding China) Antibody Drug Conjugates Market Size & Forecast (2018-2029)
5.2.8 Latin America Antibody Drug Conjugates Market Size & Forecast (2018-2029)
5.2.9 Middle East & Africa Antibody Drug Conjugates Market Size & Forecast (2018-2029)
6 North America
6.1 North America Antibody Drug Conjugates Revenue by Players
6.2 North America Antibody Drug Conjugates Revenue by Types
6.3 North America Antibody Drug Conjugates Revenue by Applications
6.4 North America Antibody Drug Conjugates Market by Countries
6.4.1 North America Antibody Drug Conjugates Revenue by Countries (2018-2029)
6.5 United States
6.6 Canada
7 China
7.1 China Antibody Drug Conjugates Revenue by Players
7.2 China Antibody Drug Conjugates Revenue by Types
7.3 China Antibody Drug Conjugates Revenue by Applications
7.4 China
8 Asia Pacific (Excluding China)
8.1 Asia Pacific Antibody Drug Conjugates Revenue by Players
8.2 Asia Pacific Antibody Drug Conjugates Revenue by Types
8.3 Asia Pacific Antibody Drug Conjugates Revenue by Applications
8.4 Asia Pacific Antibody Drug Conjugates Market by Countries
8.4.1 Asia Pacific Antibody Drug Conjugates Revenue by Countries (2018-2029)
8.5 Japan
8.6 Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Europe
9.1 Europe Antibody Drug Conjugates Revenue by Players
9.2 Europe Antibody Drug Conjugates Revenue by Types
9.3 Europe Antibody Drug Conjugates Revenue by Applications
9.4 Europe Antibody Drug Conjugates Market by Countries
9.4.1 Europe Antibody Drug Conjugates Revenue by Countries (2018-2029)
9.5 Germany
9.6 France
9.7 UK
9.8 Italy
9.9 Russia
9.10 Nordic
10 Latin America
10.1 Latin America Antibody Drug Conjugates Revenue by Players
10.2 Latin America Antibody Drug Conjugates Revenue by Types
10.3 Latin America Antibody Drug Conjugates Revenue by Applications
10.4 Latin America Antibody Drug Conjugates Market by Countries
10.4.1 Latin America Antibody Drug Conjugates Revenue by Countries (2018-2029)
10.5 Brazil
10.6 Argentina
10.7 Mexico
11 Middle East & Africa
11.1 Middle East & Africa Antibody Drug Conjugates Revenue by Players
11.2 Middle East & Africa Antibody Drug Conjugates Revenue by Types
11.3 Middle East & Africa Antibody Drug Conjugates Revenue by Applications
11.4 Middle East & Africa Antibody Drug Conjugates Market by Countries
11.4.1 Middle East & Africa Antibody Drug Conjugates Revenue by Countries (2018-2029)
11.5 Egypt
11.6 South Africa
11.7 Israel
11.8 Turkey
11.9 GCC Countries
12 Antibody Drug Conjugates Industry Dynamic Analysis
12.1 Antibody Drug Conjugates Market Trends Analysis
12.2 Antibody Drug Conjugates Market Drivers Analysis
12.3 Antibody Drug Conjugates Market Challenges Analysis
12.4 Antibody Drug Conjugates Market Restraints Analysis
12.5 Antibody Drug Conjugates Industry Mergers & Acquisitions
12.6 Antibody Drug Conjugates Industry New Entrants and Expansion Plans
13 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Post-Covid-19 Epidemic Era, Antibody Drug Conjugates Industry Development Trend Analysis Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?